This Advisory Notice supersedes RA1518-5 and is being issued to accurately reflect the slight differences in Rule 559 (“Position Limits and Exemptions”) and Rule 560 (“Position Accountability”) across CME Group Exchanges. These differences do not affect the guidance described in the original Advisory Notice (RA1518-5). No other changes have been made to the original Advisory Notice.
Click HERE to view full advisory.
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.